Greg Deener, BS

iCell Gene Therapeutics Inc.
Henrico, VA, United States

Greg Deener is CEO of iCell Gene Therapeutics. iCell is a leading cell therapy company and treated the first Lupus autoimmune patient with CAR-T

Presentation(s):

• 1493: Novel BCMA-CD19 Compound CAR-T (cCAR) Targets B Cells and Plasma Cells Achieving Immune Reset and Eliminates All Autoantibodies in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) Patients Resulting in Long-Term, Medication-Free Remission

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.